Business Context and Reporting Period
Company: Pacific Biosciences of California, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 11, 2016
Subject: Regulation FD Disclosure regarding an update on the launch of the Sequel System, originally launched in October 2015.
Key Financial Metrics
This filing is a qualitative update and does not contain specific financial statements. The text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing reports a progress update on the Sequel System launch. No quantitative material changes to financial position are disclosed in this document.
Guidance, Outlook, and Management Commentary
- Management Commentary: Dr. Hunkapiller is scheduled to provide details on the Company's progress at the JP Morgan 34th Annual Healthcare Conference on January 12, 2016, at 1:30 p.m. PST.
- Availability: The discussion will be webcast live and available for replay on the company's investor website.
- Disclosure Status: The information is furnished under Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific details of the Sequel System progress update in the press release (Exhibit 99.1) referenced in this filing.
- Review the webcast replay of the January 12, 2016, JP Morgan Healthcare Conference presentation for management's detailed outlook.
- Confirm that no material financial data was omitted from this 8-K, as it serves only as a notification of the update.